SAFETY AND EFFICACY OF INTRA-RENAL ARTERIAL AUTOLOGOUS CD34+CELL TRANSFUSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A RANDOMIZED, OPEN-LABEL, CONTROLLED PHASE II CLINICAL TRIAL

被引：0
|
作者：
Yang, Chihchao [1 ,2 ]
Li, Yi-Chen [1 ,3 ]
Yip, Honkan [1 ,3 ]
机构：
[1] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[2] Chang Gung Univ, Div Nephrol, Dept Internal Med, Coll Med, Kaohsiung, Taiwan
[3] Chang Gung Univ, Coll Med, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0182
引用
收藏
页码：484 / 484
页数：1
相关论文
共 50 条
  • [21] A Phase 3, Randomized, Partially Blinded, Active-Controlled, Study Assessing the Efficacy and Safety of Intramyocardial Autologous CD34+Cell Administration in Patients with Refractory Angina: Design of the RENEW Study
    Povsic, Thomas I.
    Losordo, Douglas W.
    Story, Kenneth
    Junge, Candice E.
    Schatz, Richard A.
    Harrington, Robert A.
    Davidson, Charles J.
    Fortuin, David F.
    Kereiakes, Dean J.
    Mendelsohn, Farrell O.
    Sherman, Warren
    Henry, Timothy D.
    CIRCULATION, 2012, 126 (21)
  • [22] Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial
    Wang, Leiping
    Cao, Jun
    Li, Chunlei
    Wang, Xiaodong
    Zhao, Yannan
    Li, Ting
    Du, Yiqun
    Tao, Zhonghua
    Peng, Wenxia
    Wang, Biyun
    Zhang, Jian
    Zhang, Sheng
    Wang, Zhonghua
    Hu, Xichun
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (02) : 330 - 339
  • [23] Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial
    Leiping Wang
    Jun Cao
    Chunlei Li
    Xiaodong Wang
    Yannan Zhao
    Ting Li
    Yiqun Du
    Zhonghua Tao
    Wenxia Peng
    Biyun Wang
    Jian Zhang
    Sheng Zhang
    Zhonghua Wang
    Xichun Hu
    Investigational New Drugs, 2022, 40 : 330 - 339
  • [24] Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial
    Cao, Yongsheng
    Cao, Shujie
    Zhao, Jiangang
    Zhao, Jianqin
    Zhao, Yanan
    Liu, Ying
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [25] Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34+ cell therapy: A clinical trial
    Ohtake, Takayasu
    Sato, Tsutomu
    Tsukiyama, Toshitaka
    Muraoka, Suguru
    Mitomo, Ayaka
    Maruyama, Haruka
    Yamano, Mizuki
    Mochida, Yasuhiro
    Ishioka, Kunihiro
    Oka, Machiko
    Moriya, Hidekazu
    Hidaka, Sumi
    Masuda, Haruchika
    Asahara, Takayuki
    Kobayashi, Shuzo
    WORLD JOURNAL OF STEM CELLS, 2024, 16 (12):
  • [26] EFFECT OF EMPAGLIFLOZIN/LINAGLIPTIN ON OXIDATIVE STRESS MARKERS IN CHRONIC KIDNEY DISEASE PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED, OPEN-LABEL CONTROLLED TRIAL
    Suebsiripong, Supaporn
    Inkong, Pitchamon
    Chaiprasert, Amnart
    Nata, Naowanit
    Tasanavipas, Pamila
    Varothai, Narittaya
    Thimachai, Paramat
    Supasyndh, Ouppatham
    Satirapoj, Bancha
    NEPHROLOGY, 2021, 26 : 33 - 34
  • [27] The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial
    Kulagin, Aleksandr D.
    Bakirov, Bulat A.
    Davydkin, Igor L.
    Elykomov, Ilya, V
    Konstantinova, Tatiana S.
    Korobkin, Aleksandr, V
    Kosinova, Marina, V
    Mazurov, Vadim, I
    Minaeva, Natalia, V
    Proidakov, Andrei, V
    Ptushkin, Vadim V.
    Shatokhin, Yuri, V
    Lin'kova, Yulia N.
    Zinkina-Orikhan, Arina, V
    Morozova, Maria A.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (11) : 1340 - 1348
  • [28] An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis
    Anna Wasilewska
    Rose Ann Murray
    Aimee Sundberg
    Sharif Uddin
    Heinrich Achenbach
    Aleksey Shavkin
    Tamás Szabó
    Andrea Vergani
    Obi Umeh
    BMC Nephrology, 23
  • [29] Tocilizumab in Systemic Sclerosis Interstitial Lung Disease: Safety and Efficacy in the Double-Blind and Open-Label Periods of a Randomized Controlled Phase 3 Trial
    Khanna, D.
    Linz, C. J. F.
    Furst, D. E.
    Zucchetto, M.
    Raghu, G.
    Martinez, F. J.
    Denton, C. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [30] An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis
    Wasilewska, Anna
    Murray, Rose Ann
    Sundberg, Aimee
    Uddin, Sharif
    Achenbach, Heinrich
    Shavkin, Aleksey
    Szabo, Tamas
    Vergani, Andrea
    Umeh, Obi
    BMC NEPHROLOGY, 2022, 23 (01)
12345